Publication: Disulfide-linked liposomes: Effective delivery vehicle for Bcl-2 antisense oligodeoxyribonucleotide G3139
| dc.contributor.author | Weecharangsan W. | |
| dc.contributor.author | Yu B. | |
| dc.contributor.author | Liu S. | |
| dc.contributor.author | Pang J.X. | |
| dc.contributor.author | Lee L.J. | |
| dc.contributor.author | Marcucci G. | |
| dc.contributor.author | Lee R.J. | |
| dc.date.accessioned | 2021-04-05T03:37:05Z | |
| dc.date.available | 2021-04-05T03:37:05Z | |
| dc.date.issued | 2010 | |
| dc.date.issuedBE | 2553 | |
| dc.description.abstract | Background: Disulfide-linked oligodeoxyribonucleotide (ODN) liposomes were formulated and evaluated for the delivery of antisense ODN G3139 in KB human oral carcinoma cells. Materials and Methods: Liposomes composed of 1,2-di-(9Z-octadecenoyl)-3-trimethylammo-nium-propane(DOTAP)/egg phosphatidylcholine/α-tocopheryl polyethylene glycol 1000 succinate were incorporated with hydrophobized disulfide-linked ODN. Disulfide-linked ODN liposomes were characterized for their size, ODN intracellular delivery, Bcl-2 mRNA and protein expression, growth inhibition, and chemosensitization. Results: Intracellular delivery of ODN with disulfide-linked ODN liposomes was more efficient than that with non-liposomal hydrophobized disulfide-linked ODN. Treatment of the cells with disulfide-linked ODN liposomes resulted in efficient Bcl-2 down-regulation greater than that with hydrophobized disulfide-linked ODN and consistent with that of cellular growth inhibition and the sensitization to daunorubicin in KB cells. Disulfide-linked ODN liposomes exhibited superior colloidal stability during 5-week storage. Conclusion: Disulfide-linked liposomes are effective delivery vehicles for antisense ODN. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Anticancer Research. Vol 30, No.1 (2010), p.31-38 | |
| dc.identifier.issn | 2507005 | |
| dc.identifier.other | 2-s2.0-77649246832 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/7666 | |
| dc.rights.holder | Scopus | |
| dc.subject.other | 1,2 dioleoyl 3 trimethylammoniopropane | |
| dc.subject.other | Daunorubicin | |
| dc.subject.other | Disulfide linked liposome | |
| dc.subject.other | Liposome | |
| dc.subject.other | Macrogol derivative | |
| dc.subject.other | Messenger RNA | |
| dc.subject.other | Oblimersen | |
| dc.subject.other | Phosphatidylcholine | |
| dc.subject.other | Polyethylene glycol 1000 succinate | |
| dc.subject.other | Protein bcl 2 | |
| dc.subject.other | Unclassified drug | |
| dc.subject.other | Article | |
| dc.subject.other | Cell growth | |
| dc.subject.other | Cell strain KB | |
| dc.subject.other | Chemosensitization | |
| dc.subject.other | Controlled study | |
| dc.subject.other | Down regulation | |
| dc.subject.other | Growth inhibition | |
| dc.subject.other | Human | |
| dc.subject.other | Human cell | |
| dc.subject.other | Intracellular transport | |
| dc.subject.other | Mouth carcinoma | |
| dc.subject.other | Nonviral gene delivery system | |
| dc.subject.other | Priority journal | |
| dc.subject.other | Protein expression | |
| dc.subject.other | Antibiotics, Antineoplastic | |
| dc.subject.other | Cell Growth Processes | |
| dc.subject.other | Colloids | |
| dc.subject.other | Daunorubicin | |
| dc.subject.other | Disulfides | |
| dc.subject.other | Down-Regulation | |
| dc.subject.other | Drug Stability | |
| dc.subject.other | Genes, bcl-2 | |
| dc.subject.other | Humans | |
| dc.subject.other | KB Cells | |
| dc.subject.other | Liposomes | |
| dc.subject.other | Oligodeoxyribonucleotides, Antisense | |
| dc.subject.other | Transfection | |
| dc.title | Disulfide-linked liposomes: Effective delivery vehicle for Bcl-2 antisense oligodeoxyribonucleotide G3139 | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-77649246832&partnerID=40&md5=58a80b4e5e45b2b1ee0f7b97fed14f3f |
